Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 14, 2020, to announce preliminary, unaudited sales results for the fourth quarter and full year ended December 31, 2019. The filing primarily serves as a vehicle to disseminate this important sales update to investors ahead of their full financial report. While specific sales figures are detailed in the accompanying press release (Exhibit 99.1), this 8-K itself does not contain the detailed financial statements or management discussion and analysis typically found in a quarterly or annual report.
Key Highlights
- 1Boston Scientific announced preliminary sales results for Q4 and full year 2019 via an 8-K filing.
- 2The announcement was made on January 14, 2020, based on information as of January 13, 2020.
- 3The key information is contained within the attached press release (Exhibit 99.1).
- 4This filing focuses solely on sales results and does not include comprehensive financial statements or operational details.
- 5The information provided is preliminary and unaudited.
- 6This 8-K is an informational update rather than a detailed financial disclosure.